Category: US Equity Markets

US Equity Markets

Zepp Health Stock Jumps 34% As Quarterly Revenue Surges

Zepp Health Corporation (NYSE: ZEPP) shares posted a significant rally in the latest session as the company delivered robust financial results. ZEPP stock advanced 34.00%, closing at $17.42. Revenue Growth Driven by Amazfit Products ZEPP reported revenue of US$59.4 million

US Equity Markets

Investor Optimism Grows As Aehr Expands Role In AI Processor Market

Aehr Test Systems, Inc. (NASDAQ: AEHR) experienced a significant market surge on Tuesday, with its stock climbing 22.19% to close at $20.10. The sharp increase followed the company’s announcement of a substantial order from its principal artificial intelligence (AI) processor

US Equity Markets

Lixte Biotechnology (LIXT) Shares Climb Sharply On Equity Deal Closure

Following the successful conclusion of a $5.0 million private placement, Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) saw a notable spike in its share price on Wednesday, ending at $2.02, representing a dramatic jump of 71.19%. In line with Nasdaq’s market-based

US Equity Markets

GlucoTrack (GCTK) Gains Momentum On Encouraging Clinical Data Release

After GlucoTrack, Inc. (NASDAQ: GCTK) released encouraging results from its first-in-human clinical research, the company’s shares surged 26.25% to $7.84 during the previous session. The results were presented last week in Chicago at the American Diabetes Association’s (ADA) 85th Scientific

US Equity Markets

Strong Q2 2024 Results Propel Iovance (IOVA) Stock

On Friday, investor confidence in shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) increased significantly. After the firm released its Financial Results and Corporate Updates for the second quarter of 2024, that resulted in a price increase of 24.94%. The stock

US Equity Markets

Significant Contract Boosts Comtech (CMTL) Stock

The stock price of Comtech Telecommunications Corp. (NASDAQ: CMTL) has increased significantly following the acquisition of a new and noteworthy contract. CMTL shares were up 7.66% to $2.39 as of the most recent update during the current trading session. Partnership

US Equity Markets

Equity Move Propels Bicycle Therapeutics (BCYC) Shares

Following the announcement of an equity initiative, shares of Bicycle Therapeutics plc (NASDAQ: BCYC) are experiencing a notable increase. As of the last check this current session, BCYC stock has risen by 17.88%, reaching $25.25. Securities Purchase Agreement And Financing

Comet Report
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.